From the Departments of Neuroradiology (S.B., T.H., T.B.B., B.W., C.Z., J.S.K.), Neurosurgery (J.G., F.R., B.M.), and Statistics and Epidemiology (V.K.), Klinikum Rechts der Isar, Technische Universität München, Ismaningerstr 22, 81675 Munich, Germany.
Radiology. 2017 May;283(2):499-507. doi: 10.1148/radiol.2016152832. Epub 2016 Oct 19.
Purpose To analyze if fractional anisotropy (FA) in nonenhancing peritumoral regions (NEPTRs) at baseline is associated with later tumor recurrence in glioblastoma. Materials and Methods Ethical approval was obtained for this retrospective, HIPAA-compliant study. FA was measured in 70 patients with glioblastoma in five regions of interest (ROIs) per patient in the NEPTR at preoperative magnetic resonance (MR) imaging with (166 regions) or without (184 regions) local contrast-enhancing tumor recurrence at follow-up MR imaging (median, 7.3 months; range, 0.9-46.6 months). ROIs were classified according to their location (white matter, cortex, fiber tracts, basal ganglia). Ratio of FA in the ROI of the NEPTR to that in the contralateral side (FA) and to that in the internal capsule (FA) was calculated. A generalized linear mixed model was performed. Ten-fold cross-validation was used for the receiver operating characteristics (ROC) analysis. Results FA and FA were significantly lower in regions with later tumor recurrence than in regions without (median FA: 0.29 [interquartile range {IR}, 0.22-0.36] vs 0.46 [IR, 0.38-0.57]; median FA: 0.20 [IR, 0.16-0.24] vs 0.29 [IR, 0.22-0.36], respectively). ROC analysis revealed an area under the ROC curve of 0.893 for FA and of 0.815 for FA, resulting in respective sensitivity and specificity of 85.5% and 84.2% for FA and 86.7% and 66.8% for FA. Conclusion Local tumor recurrence in the NEPTR may be predicted by FA metrics at baseline in patients with glioblastoma. This might be important for surgery or radiation planning. RSNA, 2016 Online supplemental material is available for this article.
目的 分析初诊时非增强瘤周区(NEPTR)的各向异性分数(FA)是否与胶质母细胞瘤(GBM)的肿瘤复发有关。
材料与方法 本回顾性 HIPAA 合规研究获得了伦理批准。对术前磁共振成像(MRI)中 70 例 GBM 患者的 5 个感兴趣区(ROI)中的 NEPTR 进行 FA 测量,这些患者在随访 MRI 中(中位数为 7.3 个月,范围为 0.9-46.6 个月)有(166 个 ROI)或无(184 个 ROI)局部增强肿瘤复发。根据 ROI 位置(白质、皮质、纤维束、基底节)对 ROI 进行分类。计算 NEPTR 中 ROI 的 FA 与对侧侧 FA(FA)和内囊 FA(FA)的比值。采用广义线性混合模型进行分析。采用 10 倍交叉验证进行受试者工作特征(ROC)分析。
结果 与无肿瘤复发的 ROI 相比,有肿瘤复发的 ROI 中的 FA 和 FA 明显较低(中位数 FA:0.29[四分位数间距{IR},0.22-0.36]比 0.46[IR,0.38-0.57];中位数 FA:0.20[IR,0.16-0.24]比 0.29[IR,0.22-0.36])。ROC 分析显示 FA 的 ROC 曲线下面积为 0.893,FA 的 ROC 曲线下面积为 0.815,FA 的灵敏度和特异性分别为 85.5%和 84.2%,FA 的灵敏度和特异性分别为 86.7%和 66.8%。
结论 在 GBM 患者中,FA 指标可能可以预测 NEPTR 中的局部肿瘤复发。这对于手术或放疗计划可能很重要。
放射学学会,2016 年
在线补充材料可从本文获取。